Sep 13, 2022 / 02:35PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
Hey, everyone. Good morning. My name is Tejas Savant, I'm the life science tools and diagnostics analyst at Morgan Stanley. It's my pleasure to host 10x Genomics this morning. And with us, we have Serge Saxonov, CEO; and Justin McAnear, our CFO. Thanks gents, for being here. Before we get started, just need to rattle off the disclosure statement. Please see the Morgan Stanley research website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.
Questions and Answers:
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity AnalystSo with that, Serge, before we begin, could you just take a couple of minutes to just talk us through where the business is today, some of the challenges you've encountered over the last few months? And what are you most excited about looking to 2023?
Serge Saxonov - 10x Genomics, Inc. - Co-Founder, CEO & Director
So in terms of -- so kind of stepping